Israel’s BiondVax has received FDA approval of its application to proceed with clinical trials of its universal Multimeric-001 flu vaccine (M-001).

http://www.prnewswire.com/news-releases/biondvax-announces-fda-acceptance-of-ind-application-for-its-investigational-universal-flu-vaccine-507856431.html